Five-year follow-up of a phase 2 study of ibrutinib plus fludarabine, cyclophosphamide, and rituximab as initial therapy in CLL
- Resource Type
- Article
- Authors
- Ahn, Inhye E.; Brander, Danielle M.; Ren, Yue; Zhou, Yinglu; Tyekucheva, Svitlana; Walker, Heather A.; Black, Robert; Montegaard, Josie; Alencar, Alvaro; Shune, Leyla; Omaira, Mohammad; Jacobson, Caron A.; Armand, Philippe; Ng, Samuel Y.; Crombie, Jennifer; Fisher, David C.; LaCasce, Ann S.; Arnason, Jon; Hochberg, Ephraim P.; Takvorian, Ronald W.; Abramson, Jeremy S.; Brown, Jennifer R.; Davids, Matthew S.
- Source
- In Blood Advances 27 February 2024 8(4):832-841
- Subject
- Clinical Trials and Observations
Lymphoid Neoplasia
- Language
- ISSN
- 2473-9529